drugset / Trial / NCT03610048
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the long-term safety and tolerability of ALKS 5461 as an adjunctive treatment for refractory MDD.
Timeline
- Start
- 2018-08-09
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | Subcutaneous |
| Subject | Samidorphan | Small molecule | — | Subcutaneous |